-
公开(公告)号:US08715733B2
公开(公告)日:2014-05-06
申请号:US11189336
申请日:2005-07-26
IPC分类号: A61K38/18
CPC分类号: A61L27/3654 , A61K35/32 , A61K35/35 , A61K38/20 , A61K38/2264 , A61L27/3604 , A61L27/3658 , A61L27/3683 , A61L27/3804 , A61L27/3852 , A61L27/3856 , A61L27/54 , A61L2300/252 , A61L2300/414 , A61L2300/426 , A61L2300/434 , A61L2430/38 , A61K2300/00
摘要: An enhanced adipose tissue containing native adipose tissue and a concentrated amount of an active agent derived from adipose tissue, wherein the enhanced adipose tissue is preferably injected into the intervertebral disc of a patient suffering from degenerative disc disease.
摘要翻译: 含有天然脂肪组织和浓缩量的源自脂肪组织的活性剂的增强的脂肪组织,其中增强的脂肪组织优选注射到患有退行性椎间盘疾病的患者的椎间盘中。
-
22.Transdiscal administration of specific inhibitors of pro-inflammatory cytokines 有权
标题翻译: 跨时间给药促炎细胞因子的特异性抑制剂公开(公告)号:US20090175943A1
公开(公告)日:2009-07-09
申请号:US12291378
申请日:2008-11-07
申请人: Mohamed Attawia , Thomas M. DiMauro , Hassan Serhan , Sudhakar Kadiyala , David Urbahns , Scott Bruder
发明人: Mohamed Attawia , Thomas M. DiMauro , Hassan Serhan , Sudhakar Kadiyala , David Urbahns , Scott Bruder
IPC分类号: A61K9/10 , A61K39/395
CPC分类号: A61K35/28 , A61B5/055 , A61B17/7061 , A61K9/0012 , A61K9/0019 , A61K9/0085 , A61K35/32 , A61K38/17 , A61K38/1793 , A61K38/18 , A61K38/1841 , A61K38/1875 , A61K38/20 , A61K38/363 , A61K38/4833 , A61K39/395 , A61K39/3955 , A61K45/06 , A61K47/34 , C12Y304/21005 , G01N33/6869 , G01N2333/54
摘要: The present invention relates to injecting a high specificity cytokine antagonist into a diseased intervertebral disc.
摘要翻译: 本发明涉及将高特异性细胞因子拮抗剂注射到患病的椎间盘中。
-
公开(公告)号:US07429378B2
公开(公告)日:2008-09-30
申请号:US10610355
申请日:2003-06-30
申请人: Hassan Serhan , Thomas M. DiMauro , Mohamed Attawia , Sudhakar Kadiyala , David Urbahns , Scott Bruder , Laura J. Brown , Jeffrey C. Geesin
发明人: Hassan Serhan , Thomas M. DiMauro , Mohamed Attawia , Sudhakar Kadiyala , David Urbahns , Scott Bruder , Laura J. Brown , Jeffrey C. Geesin
IPC分类号: A61K35/00
CPC分类号: A61K38/1841 , A61K35/28 , A61K38/57 , A61K2300/00
摘要: The present invention relates to injecting a high affinity antagonist of MMPs into a diseased intervertebral disc.
摘要翻译: 本发明涉及将MMP的高亲和力拮抗剂注射到患病的椎间盘中。
-
公开(公告)号:US20080213261A1
公开(公告)日:2008-09-04
申请号:US11881926
申请日:2007-07-30
申请人: Thomas M. DiMauro , Hassan Serhan , Mohamed Attawia , Sudhakar Kadiyala , David Urbahns , Scott Bruder
发明人: Thomas M. DiMauro , Hassan Serhan , Mohamed Attawia , Sudhakar Kadiyala , David Urbahns , Scott Bruder
IPC分类号: A61K39/395 , A61K35/00 , A61P19/00 , A61K35/12
CPC分类号: A61K35/28 , A61B5/055 , A61B17/7061 , A61K9/0012 , A61K9/0019 , A61K9/0085 , A61K35/32 , A61K38/17 , A61K38/1793 , A61K38/18 , A61K38/1841 , A61K38/1875 , A61K38/20 , A61K38/363 , A61K38/4833 , A61K39/395 , A61K39/3955 , A61K45/06 , A61K47/34 , C12Y304/21005 , G01N33/6869 , G01N2333/54
摘要: The present invention relates to injecting a high specificity cytokine antagonist into a diseased intervertebral disc.
-
公开(公告)号:US07351423B2
公开(公告)日:2008-04-01
申请号:US11189691
申请日:2005-07-26
IPC分类号: A61F2/00
CPC分类号: A61K9/0024 , A61F2/08 , A61F2002/0894 , A61F2250/0035 , A61F2250/0068 , A61L27/54 , A61L27/56 , A61L2300/414 , A61L2300/432 , A61L2300/45 , A61L2300/602
摘要: This invention relates to an implant for a musculoskeletal defect having a bioactive agent having a concentration gradient.
摘要翻译: 本发明涉及具有浓度梯度的生物活性剂的肌骨骼缺损植入物。
-
公开(公告)号:US08137408B2
公开(公告)日:2012-03-20
申请号:US11928025
申请日:2007-10-30
申请人: Sudhakar Kadiyala , Scott Bruder
发明人: Sudhakar Kadiyala , Scott Bruder
IPC分类号: A61F2/28
CPC分类号: A61L27/425 , A61F2/08 , A61F2/28 , A61F2/30756 , A61F2002/2835 , A61F2002/2842 , A61L27/3608 , A61L27/3645 , A61L27/3683 , A61L27/3804 , A61L27/3843
摘要: This invention relates to a musculoskeletogenic MSG graft composite made from whole bone marrow aspirate BMA having native levels of musculoskeletal progenitor cells MSPCs, comprising: a) a suspension of fractionated BMA comprising: i) MSPCs present at a level greater than their native level in whole BMA, and ii) red blood cells RBCs present at a level less than their native level in whole BMA, and b) a porous sterile matrix having an average pore size of at least 20 μm.
摘要翻译: 本发明涉及由具有天然水平的肌骨骼祖细胞MSPC的全骨髓吸出物BMA制备的肌肉发生性MSG接枝复合物,其包含:a)分级BMA的悬浮液,其包含:i)整体上存在的水平大于其天然水平的MSPC BMA,和ii)在整个BMA中存在的水平低于其天然水平的红细胞RBC,以及b)具有至少20μm的平均孔径的多孔无菌基质。
-
公开(公告)号:US08067397B2
公开(公告)日:2011-11-29
申请号:US12454200
申请日:2009-05-14
申请人: Mohamed Attawia , Thomas M. DiMauro , Hassan Serhan , Sudhakar Kadiyala , David Urbahns , Gregory Collins , Laura J. Brown , Jeffrey C. Geesin
发明人: Mohamed Attawia , Thomas M. DiMauro , Hassan Serhan , Sudhakar Kadiyala , David Urbahns , Gregory Collins , Laura J. Brown , Jeffrey C. Geesin
CPC分类号: A61K31/65 , A61K38/20 , A61K45/06 , A61K2300/00
摘要: The present invention relates to administering a doxycycline compound into a diseased intervertebral disc.
摘要翻译: 本发明涉及将多西环素化合物给予患病的椎间盘。
-
公开(公告)号:US20110253583A1
公开(公告)日:2011-10-20
申请号:US13172808
申请日:2011-06-29
申请人: Sudhakar Kadiyala
发明人: Sudhakar Kadiyala
IPC分类号: B65D85/00
CPC分类号: A61L2/0017 , A61B17/06166 , A61B2017/00004 , A61F2002/2835 , A61F2002/30062 , A61F2002/30766 , A61F2210/0004 , A61F2310/00365 , A61L2/0088 , A61L2/0094 , A61L2/022 , A61L2/081 , A61L2/206 , A61L2202/24
摘要: This invention relates to new methods & kits that minimize the risks and challenges associated with sterilization of multi-component medical devices.
摘要翻译: 本发明涉及最小化与多组分医疗装置的灭菌相关的风险和挑战的新方法和试剂盒。
-
公开(公告)号:US20090324558A1
公开(公告)日:2009-12-31
申请号:US12454200
申请日:2009-05-14
申请人: Mohamed Attawia , Thomas M. DiMauro , Hassan Serhan , Sudhakar Kadiyala , David Urbahns , Gregory Collins , Laura J. Brown , Jeffrey C. Geesin
发明人: Mohamed Attawia , Thomas M. DiMauro , Hassan Serhan , Sudhakar Kadiyala , David Urbahns , Gregory Collins , Laura J. Brown , Jeffrey C. Geesin
CPC分类号: A61K31/65 , A61K38/20 , A61K45/06 , A61K2300/00
摘要: The present invention relates to administering a doxycycline compound into a diseased intervertebral disc.
摘要翻译: 本发明涉及将多西环素化合物给予患病的椎间盘。
-
公开(公告)号:US07175336B2
公开(公告)日:2007-02-13
申请号:US09771433
申请日:2001-01-26
申请人: John C. Voellmicke , Stephen W. Connolly , Sudhakar Kadiyala , Scott P. Bruder , David Urbahns , Kazuna Tanaka , Jeffrey Kapec , Yukiko Naoi
发明人: John C. Voellmicke , Stephen W. Connolly , Sudhakar Kadiyala , Scott P. Bruder , David Urbahns , Kazuna Tanaka , Jeffrey Kapec , Yukiko Naoi
CPC分类号: A61F2/4644 , A61B2017/00495 , A61F2/4405 , A61F2/4455 , A61F2/4601 , A61F2002/2835 , A61F2002/30713 , A61F2250/0087 , A61J1/2031 , A61J1/2037 , A61J1/2055 , A61J1/2058 , A61J1/2062 , A61J1/2075 , A61J1/2096
摘要: The invention relates to a manifold for mixing biomedical fluids having superior stability and minimal susceptibility to clotting.
摘要翻译: 本发明涉及用于混合生物医学流体的歧管,其具有优异的稳定性和对凝结的最小的易感性。
-
-
-
-
-
-
-
-
-